📰 Full Story
Venture capital invested in Irish tech small and medium-sized enterprises fell 58% in Q1 2026 to €221.7 million, the Irish Venture Capital Association (IVCA) said on May 24.
The decline follows an exceptionally strong Q1 2025 when Irish firms raised €532.8m.
International investors provided 85% of capital this quarter.
Life sciences dominated deals, accounting for 54% (€119.5m) of funding, followed by fintech (€28m) and software (€26.9m); AI was classified as just 2% of the total despite global AI-driven dealflow.
Deal-size bands shrank across the board except for transactions under €1m; investment in the €3m–€5m band fell to €7.9m (down 77%) and €5m–€10m fell to €16.5m (down 62%). Top rounds included Neurent Medical (€62.5m), Aerska (€33m), Evervault (€21m), Circit (€20m) and XFuel (€18.5m). IVCA leaders noted Ireland’s exposure to overseas capital and warned that geopolitical headwinds, including the Iran war, could affect investor confidence, while government measures — such as a €250m Seed and Venture Capital Scheme and higher Enterprise Ireland direct investment limits — should begin to support early-stage funding.
🔗 Based On
The Irish TimesVenture funding for Irish tech SMEs falls
Irish Independent6:03 PMFunding for Irish tech startups slumps as AI hoovers up investors’ resources
Silicon RepublicVC funding in Irish SMEs falls 58pc in Q1, IVCA finds





💬 Commentary